Amgen

Amgen Inc. is a global biotechnology company based in Thousand Oaks, California. Founded in 1980, Amgen specializes in developing and commercializing biologic medicines using recombinant DNA technology. The company focuses on treating serious illnesses, including anemia, cancer, inflammatory diseases, bone disorders, cardiovascular conditions, and rare diseases. Amgen has achieved significant milestones in its history, including the FDA approval of key products like Epogen for anemia and Neupogen for chemotherapy-induced neutropenia. The company has expanded its portfolio through strategic acquisitions, such as Immunex, and has introduced innovative treatments like Repatha for high cholesterol and Tepezza for thyroid eye disease. With a commitment to patient access and responsibility, Amgen continues to lead in biotechnology, emphasizing the development of biologics for diseases with limited treatment options.